Arrowhead Pharma (ARWR) PT Raised to $62 at Piper Sandler
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $85.06 -0.62%
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Sandler analyst Edward A. Tenthoff raised the price target on Arrowhead Pharma (NASDAQ: ARWR) to $62.00 (from $59.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
- Pou Sheng International (Holdings) Limited (3813:HK) (PSHGF) PT Raised to HK$0.54 at Goldman Sachs
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
